22642833|t|Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
22642833|a|BACKGROUND: The interaction between the membrane glycoprotein, CD200 and its cognate receptor CD200 receptor (CD200R), has been shown to play a role in maintaining microglia in a quiescent state. There is evidence of increased activation under resting and stimulated conditions in microglia prepared from CD200-deficient mice compared with wild-type mice, whereas activation of the receptor by CD200 fusion protein (CD200Fc) ameliorates inflammatory changes which are evident in the central nervous system (CNS) of the mouse model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE) and also in the hippocampus of aged rats. Additionally, an inverse relationship between microglial activation and expression of CD200 has been observed in animals treated with lipopolysaccharide (LPS) or amyloid-beta (Abeta). METHODS: We assessed the effect of CD200R activation by CD200Fc on Abeta-induced production of the pro-inflammatory cytokines, interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNFalpha) and the expression of microglial activation markers, CD68 and CD40 in cultured glia. The role played by downstream of tyrosine kinase 2 (Dok2) phosphorylation in mediating the effects of CD200R activation was evaluated by siRNA knockdown of Dok2. To further examine the impact of inflammatory changes on synaptic plasticity, the effect of CD200Fc on Abeta-induced impairment of long-term potentiation (LTP) in the CA1 region of hippocampal slices was also investigated. RESULTS: We demonstrate that Abeta-induced increases in IL-1beta, TNFalpha, CD68 and CD40 were inhibited by CD200Fc. The evidence suggests that Dok2 phosphorylation is a key factor in mediating the effect of CD200Fc, since Dok2 knockdown by siRNA abrogated its effects on microglial activation and inflammatory cytokine production. Consistent with evidence that inflammatory changes negatively impact on LTP, we show that the Abeta-induced impairment of LTP was attenuated by CD200Fc. CONCLUSIONS: The findings suggest that activation of CD200R and Dok2 is a valuable strategy for modulating microglial activation and may have therapeutic potential in neurodegenerative conditions.
22642833	0	4	Dok2	Gene	13449
22642833	41	46	Abeta	Gene	11820
22642833	135	140	CD200	Gene	17470
22642833	166	180	CD200 receptor	Gene	57781
22642833	182	188	CD200R	Gene	57781
22642833	377	382	CD200	Gene	17470
22642833	393	397	mice	Species	10090
22642833	422	426	mice	Species	10090
22642833	466	471	CD200	Gene	17470
22642833	488	495	CD200Fc	Chemical	-
22642833	509	521	inflammatory	Disease	MESH:D007249
22642833	591	596	mouse	Species	10090
22642833	606	624	multiple sclerosis	Disease	MESH:D009103
22642833	626	628	MS	Disease	MESH:D009103
22642833	631	672	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
22642833	674	677	EAE	Disease	MESH:D004681
22642833	715	719	rats	Species	10116
22642833	807	812	CD200	Gene	17470
22642833	855	873	lipopolysaccharide	Chemical	MESH:D008070
22642833	875	878	LPS	Chemical	MESH:D008070
22642833	897	902	Abeta	Gene	11820
22642833	940	946	CD200R	Gene	57781
22642833	972	977	Abeta	Gene	11820
22642833	1008	1020	inflammatory	Disease	MESH:D007249
22642833	1032	1049	interleukin-1beta	Gene	16176
22642833	1051	1059	IL-1beta	Gene	16176
22642833	1065	1092	tumor necrosis factor-alpha	Gene	24835
22642833	1094	1102	TNFalpha	Gene	24835
22642833	1157	1161	CD68	Gene	287435
22642833	1166	1170	CD40	Gene	171369
22642833	1208	1239	downstream of tyrosine kinase 2	Gene	13449
22642833	1241	1245	Dok2	Gene	13449
22642833	1291	1297	CD200R	Gene	57781
22642833	1345	1349	Dok2	Gene	13449
22642833	1384	1396	inflammatory	Disease	MESH:D007249
22642833	1454	1459	Abeta	Gene	11820
22642833	1603	1608	Abeta	Gene	11820
22642833	1630	1638	IL-1beta	Gene	16176
22642833	1640	1648	TNFalpha	Gene	21926
22642833	1650	1654	CD68	Gene	12514
22642833	1659	1663	CD40	Gene	21939
22642833	1718	1722	Dok2	Gene	13449
22642833	1797	1801	Dok2	Gene	13449
22642833	1872	1884	inflammatory	Disease	MESH:D007249
22642833	1936	1948	inflammatory	Disease	MESH:D007249
22642833	2000	2005	Abeta	Gene	11820
22642833	2112	2118	CD200R	Gene	57781
22642833	2123	2127	Dok2	Gene	13449
22642833	2226	2254	neurodegenerative conditions	Disease	MESH:D019636
22642833	Association	MESH:D004681	13449
22642833	Positive_Correlation	11820	16176
22642833	Positive_Correlation	11820	24835
22642833	Positive_Correlation	MESH:D007249	11820
22642833	Association	MESH:D004681	17470
22642833	Association	MESH:D009103	17470
22642833	Positive_Correlation	11820	21926
22642833	Association	13449	16176
22642833	Association	13449	57781
22642833	Association	MESH:D007249	24835
22642833	Positive_Correlation	11820	21939
22642833	Association	11820	13449
22642833	Bind	17470	57781
22642833	Association	MESH:D007249	13449
22642833	Association	MESH:D007249	16176
22642833	Association	MESH:D019636	57781
22642833	Positive_Correlation	11820	12514
22642833	Association	MESH:D008070	17470
22642833	Association	MESH:D007249	17470

